🎁 Black Friday: up to 50% off of annual plans
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
121.40
-2.62 (-2.11%)
Nov 20, 2026, 4:00 PM EST - Market closed

Protagonist Therapeutics Revenue

Protagonist Therapeutics had revenue of $274.41M in the quarter ending September 30, 2026, with 5,723.64% growth. This brings the company's total for the last twelve months to $551.69M, up 163.69% year-over-year. In the year 2025, Protagonist Therapeutics had annual revenue of $46.02M, down -89.41%. That makes Protagonist Therapeutics the 10,737th largest company in the world by revenue and 2,228th in the United States.

Revenue (ttm)
$551.69M
Revenue Growth
+163.69%
P/S Ratio
14.36
Revenue / Employee
$3,702,617
Employees
149
Market Cap
7.92B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202546.02M-388.42M-89.41%
Dec 31, 2024434.43M374.43M624.06%
Dec 31, 202360.00M33.42M125.73%
Dec 31, 202226.58M-776.00K-2.84%
Dec 31, 202127.36M-1.27M-4.44%
Dec 31, 202028.63M28.40M12,293.07%
Dec 31, 2019231.00K-30.69M-99.25%
Dec 31, 201830.93M10.86M54.14%
Dec 31, 201720.06M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.